Supernus Pharmaceuticals's total assets for Q4 2025 were $1.45T, an increase of 102216.88% from the previous quarter. SUPN total liabilities were $390.93B for the fiscal quarter, a 105533.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.